mazdutide – Talk Bio

Actionable Insights Powered by AI

China Approves Lilly and Innovent’s Mazdutide, Marking New Era for GLP-1 Obesity Drugs

4 weeks ago talkbio0Tagged China approval, eli lilly, GCG, GCG/GLP-1 agonist, Glucagon-Like Peptide 1, Innovent Biologics, mazdutide, N-methyl-N-2-(methylsulfinyl)ethylpropionic acid amide, Obesity, Weight maintenance regimen

Mazdutide; China approval; Innovent Biologics; Eli Lilly; GLP-1 obesity drugs; dual GCG/GLP-1 agonist; NMPA; weight management

Innovent Achieves Another Phase 3 Victory in China for Next-Generation Lilly GLP-1 Drug

1 year ago talkbio0Tagged Biological Factors, China, Diabetes, Eli Lilly, Glucagon-Like Peptide 1, Innovent, mazdutide, Phase 3 trial, Weight Loss

Innovent Biologics, Lilly, GLP-1, Mazdutide, Phase 3 Trial, Type 2 Diabetes, Weight Loss, China